GET THE APP

Revista Europea de Oncología Clínica

ISSN - 2732-2654

Volumen 6, Asunto 1 (2024)

Comunicación breve

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicación breve

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicación breve

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicación breve

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicación breve

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi